MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$244,035K
Cash and cash
equivalents
$197,078K
Accounts receivable, net
$26,735K
Prepaid expenses and
other current assets
$10,925K
Inventory
$6,326K
Total current assets
$485,099K
Intangible assets, net
$18,020K
Operating lease
right-of-use asset
$2,342K
Property and equipment,
net
$2,136K
Deposits and other
long-term assets
$230K
Total assets
$507,827K
Total liabilities and
stockholders' equity
$507,827K
Total stockholders'
equity
$441,162K
Total liabilities
$66,665K
Accumulated deficit
-$661,403K
Additional
paid-in-capital
$1,102,490K
Total current
liabilities
$60,522K
Long-term portion of
deferred revenue
$3,040K
Long-term portion of
operating lease...
$2,619K
Other long-term
liability
$484K
Accumulated other
comprehensive income
$65K
Common stock, 0.001 par
value 500,000,000...
$10K
Accrued expenses and
other current...
$54,615K
Accounts payable
$3,733K
Current portion of
deferred revenue
$2,000K
Current portion of
operating lease...
$174K
Back
Back
Balance Sheet
source: myfinsight.com
Day One Biopharmaceuticals, Inc. (DAWN)
Day One Biopharmaceuticals, Inc. (DAWN)